147 related articles for article (PubMed ID: 27747761)
41. Biologic therapies for refractory juvenile dermatomyositis: five years of experience of the Childhood Arthritis and Rheumatology Research Alliance in North America.
Spencer CH; Rouster-Stevens K; Gewanter H; Syverson G; Modica R; Schmidt K; Emery H; Wallace C; Grevich S; Nanda K; Zhao YD; Shenoi S; Tarvin S; Hong S; Lindsley C; Weiss JE; Passo M; Ede K; Brown A; Ardalan K; Bernal W; Stoll ML; Lang B; Carrasco R; Agaiar C; Feller L; Bukulmez H; Vehe R; Kim H; Schmeling H; Gerstbacher D; Hoeltzel M; Eberhard B; Sundel R; Kim S; Huber AM; Patwardhan A;
Pediatr Rheumatol Online J; 2017 Jun; 15(1):50. PubMed ID: 28610606
[TBL] [Abstract][Full Text] [Related]
42. Investigation on Brazilian clinical practices in rheumatoid arthritis: the Brazilian rheumatoid arthritis clinical practices investigation--BRACTICE.
Helfenstein M; Halpern AS; Bertolo MB
J Clin Rheumatol; 2011 Jun; 17(4 Suppl 1):S1-10. PubMed ID: 21654277
[TBL] [Abstract][Full Text] [Related]
43. Biologic or tofacitinib monotherapy for rheumatoid arthritis in people with traditional disease-modifying anti-rheumatic drug (DMARD) failure: a Cochrane Systematic Review and network meta-analysis (NMA).
Singh JA; Hossain A; Tanjong Ghogomu E; Mudano AS; Tugwell P; Wells GA
Cochrane Database Syst Rev; 2016 Nov; 11(11):CD012437. PubMed ID: 27855242
[TBL] [Abstract][Full Text] [Related]
44. Effectiveness, tolerability, and safety of subcutaneous methotrexate in early rheumatoid arthritis: A retrospective analysis of real-world data from the St. Gallen cohort.
Müller RB; von Kempis J; Haile SR; Schiff MH
Semin Arthritis Rheum; 2015 Aug; 45(1):28-34. PubMed ID: 25895697
[TBL] [Abstract][Full Text] [Related]
45. Herpes Zoster Reactivation in Patients With Rheumatoid Arthritis: Analysis of Disease Characteristics and Disease-Modifying Antirheumatic Drugs.
Pappas DA; Hooper MM; Kremer JM; Reed G; Shan Y; Wenkert D; Greenberg JD; Curtis JR
Arthritis Care Res (Hoboken); 2015 Dec; 67(12):1671-8. PubMed ID: 26018115
[TBL] [Abstract][Full Text] [Related]
46. Biologic and Targeted Synthetic DMARD Utilization in the United States: Adelphi Real World Disease Specific Programme for Rheumatoid Arthritis.
Holdsworth EA; Donaghy B; Fox KM; Desai P; Collier DH; Furst DE
Rheumatol Ther; 2021 Dec; 8(4):1637-1649. PubMed ID: 34487340
[TBL] [Abstract][Full Text] [Related]
47. [A survey on therapy strategies for rheumatoid arthritis in Chinese rheumatologists].
Wang M; Zhang L; Peng Z; Wang Y; Liu SY
Zhonghua Nei Ke Za Zhi; 2020 May; 59(5):375-379. PubMed ID: 32370467
[TBL] [Abstract][Full Text] [Related]
48. An Economic Evaluation of Tofacitinib Treatment in Rheumatoid Arthritis: Modeling the Cost of Treatment Strategies in the United States.
Claxton L; Jenks M; Taylor M; Wallenstein G; Mendelsohn AM; Bourret JA; Singh A; Moynagh D; Gerber RA
J Manag Care Spec Pharm; 2016 Sep; 22(9):1088-102. PubMed ID: 27579831
[TBL] [Abstract][Full Text] [Related]
49. Primary care physicians' perspectives towards managing rheumatoid arthritis: room for improvement.
Garneau KL; Iversen MD; Tsao H; Solomon DH
Arthritis Res Ther; 2011; 13(6):R189. PubMed ID: 22098699
[TBL] [Abstract][Full Text] [Related]
50. Baricitinib for Previously Treated Moderate or Severe Rheumatoid Arthritis: An Evidence Review Group Perspective of a NICE Single Technology Appraisal.
Ren S; Bermejo I; Simpson E; Wong R; Scott DL; Young A; Stevenson M
Pharmacoeconomics; 2018 Jul; 36(7):769-778. PubMed ID: 29502174
[TBL] [Abstract][Full Text] [Related]
51. Clinical practice variation and need for pediatric-specific treatment guidelines among rheumatologists caring for children with ANCA-associated vasculitis: an international clinician survey.
Westwell-Roper C; Lubieniecka JM; Brown KL; Morishita KA; Mammen C; Wagner-Weiner L; Yen E; Li SC; O'Neil KM; Lapidus SK; Brogan P; Cimaz R; Cabral DA;
Pediatr Rheumatol Online J; 2017 Aug; 15(1):61. PubMed ID: 28784150
[TBL] [Abstract][Full Text] [Related]
52. Side Effects of Methotrexate and Tumor Necrosis Factor Inhibitors: Differences in Tolerability Among Patients With Psoriatic Arthritis and Rheumatoid Arthritis.
Ogdie A; Maksabedian Hernandez EJ; Shaw Y; Stolshek B; Michaud K
ACR Open Rheumatol; 2022 Nov; 4(11):935-941. PubMed ID: 35971643
[TBL] [Abstract][Full Text] [Related]
53. The use of disease modifying antirheumatic drugs in women with rheumatoid arthritis of childbearing age: a survey of practice patterns and pregnancy outcomes.
Chakravarty EF; Sanchez-Yamamoto D; Bush TM
J Rheumatol; 2003 Feb; 30(2):241-6. PubMed ID: 12563675
[TBL] [Abstract][Full Text] [Related]
54. Real-world utilization of DMARDs and biologics in rheumatoid arthritis: the RADIUS (Rheumatoid Arthritis Disease-Modifying Anti-Rheumatic Drug Intervention and Utilization Study) study.
Gibofsky A; Palmer WR; Goldman JA; Lautzenheiser RL; Markenson JA; Weaver A; Schiff MH; Keystone EC; Paulus HE; Harrison MJ; Whitmore JB; Leff JA
Curr Med Res Opin; 2006 Jan; 22(1):169-83. PubMed ID: 16393443
[TBL] [Abstract][Full Text] [Related]
55. Treating rheumatoid arthritis to target: an Italian rheumatologists' survey on the acceptance of the treat-to-target recommendations.
Caporali R; Conti F; Covelli M; Govoni M; Salaffi F; Ventriglia G; Montecucco C
Clin Exp Rheumatol; 2014; 32(4):471-6. PubMed ID: 24960620
[TBL] [Abstract][Full Text] [Related]
56. How are rheumatologists from Argentina managing patients with arthralgias suspicious for progressing to rheumatoid arthritis?
Vinicki JP; Zamora JLV; Salinas RG; Alarcón GS
Clin Rheumatol; 2023 May; 42(5):1479-1483. PubMed ID: 36977950
[TBL] [Abstract][Full Text] [Related]
57. Use of Tumor Necrosis Factor-Alpha Inhibitors in Children and Young Adults With Juvenile Idiopathic Arthritis or Rheumatoid Arthritis.
Lee WJ; Briars L; Lee TA; Calip GS; Suda KJ; Schumock GT
Pharmacotherapy; 2016 Dec; 36(12):1201-1209. PubMed ID: 27779782
[TBL] [Abstract][Full Text] [Related]
58. Long-Term Efficacy of Tumor Necrosis Factor Inhibitors for the Treatment of Methotrexate-Naïve Rheumatoid Arthritis: Systematic Literature Review and Meta-Analysis.
Gulácsi L; Zrubka Z; Brodszky V; Rencz F; Alten R; Szekanecz Z; Péntek M
Adv Ther; 2019 Mar; 36(3):721-745. PubMed ID: 30637590
[TBL] [Abstract][Full Text] [Related]
59. Perceptions of Doppler ultrasound for rheumatoid arthritis disease activity assessment and education.
Joshua F; Bailey C; Marabani M; Romas E; White R; Wong P
Int J Rheum Dis; 2019 Jan; 22(1):55-61. PubMed ID: 28205411
[TBL] [Abstract][Full Text] [Related]
60. Survey of practices regarding management of early rheumatoid arthritis by rheumatologists in France.
Maravic M; Bergé C; Daurès JP; Boissier MC
Clin Exp Rheumatol; 2004; 22(3):319-27. PubMed ID: 15144126
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
